Global Pricing Innovations announces relocation of London Head office

London, November 17th, 2021

Today, Global Pricing Innovations (GPI), are pleased to announce the relocation of its Head Office in London from 17th November 2021 to support GPI’s continued growth and expansion plans. The new facility, 64 North Row, based in the heart of Mayfair, was handpicked to align with GPI’S vision for a high-tech innovative and collaborative environment, for both its clients and employees. The new office provides a larger space to facilitate GPI’s rapid growth, whilst still being able to provide the high quality, bespoke service for clients.

CEO Preeti Patel says “ I am extremely excited to announce the move to our new headquarters in London. We have spent a lot of time viewing and assessing new spaces to make sure that they reflect our brand, core values and facilitate the high quality service that we pride ourselves on. I hope that all of our clients, suppliers and employees will enjoy and make the most of the innovative and collaborative environment that 64 North Row offers.”

About GPI

GPI is a market leader in analytics and innovative solutions for biopharma pricing, market access and commercial strategy.  Headquartered London, with offices in Cambridge and Mumbai, GPI support price decision-making throughout the lifecycle and help the industry achieve day-to-day operational improvement and market access excellence.  

As a team of leading domain specialists, GPI provide high quality, curated insights and recommendations on global drug pricing strategy, market access optimisation, asset evaluation, value perception and payer behaviour.  

GPI’s suite of technology and bespoke service offerings are powered by GPI pulse™, a solution that harnesses the power of technology, data, and collective expertise to drive effective and efficient access to medicines with faster insights and sustainable pricing strategies. 

To find out more about GPI, visit or email